Dividend Declaration

Source: RNS
RNS Number : 2838K
JPMorgan UK Small Cap Grwth&Inc PLC
01 November 2024
 

JPMorgan UK Small Cap Growth & Income plc (the "Company")

 

Dividend Declaration

 

Legal Entity Identifier: 549300PXALXKUMU9JM18

Information disclosed in accordance with DTR 6.1.13

 

Second quarterly interim dividend for the year ending 31st July 2025

 

The Board of JPMorgan UK Small Cap Growth & Income plc announces that the Company's unaudited cum income Net Asset Value ('NAV') was 376.24 pence per share at close of business on 31st July 2024. Accordingly, in line with the Company's new distribution policy, the Directors have declared that a second quarterly interim dividend of 3.76 pence per share for the year ending 31st July 2025 will be paid on 2nd January 2025 to shareholders on the register at the close of business on 22nd November 2024. The ex-dividend date will be 21st November 2024.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ('DRIP'), which is managed by the Company's registrar. For details on the DRIP, please contact the Company's Registrar, Computershare Investor Services PLC. The last election date to participate in the DRIP in relation to the above dividend payment is 9th December 2024.

 

1st November 2024

For further information, please contact:

 

Lucy Dina

For and on behalf of

JPMorgan Funds Limited

0800 20 40 20 or +44 1268 44 44 70 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEASEEDFLLFFA